Welcome to My Meds Matter


Pharmacies Say FDA Is Going Too Far

In Enforcing Drug Compounding Law

Compounding pharmacies, which customize drugs for individual patients, say the FDA is overstepping its authority and jeopardizing patient access to compounded medications.

IACP Submits Comments to California State Board of Pharmacy

Major concern about committee recommendation for Beyond-Use-Dating

New rule would cut access to compounds in California, Increase costs

NCPA Supports House Bill Strengthening Patient Access to Compounded Medications

H.R. 2871, The Preserving Patient Access to Compounded Medications Act of 2017

NCPA supports Congress's efforts to assure appropriate oversight of compounding pharmacies in a way that does not curtail or hinder patient access to those specially-tailored medications.

House Committee Says FDA's Compounding Policies are Overreach

Committee Demands Radical Policy Revisions

House Appropriations Committee says FDA policies go against Congressional intent

Senator David Vitter (R-LA)

Saving Access to Compounded Medications for Special Needs Patients Act

Addresses confusion over a compounding pharmacy’s “distribution” of compounded preparations

Senator David Vitter (R-LA) introduced S. 1406, the Saving Access to Compounded Medications for Special Needs Patients Act


FDA releases draft guidance on animal drug compounding

Proposed policy lays out new rules for veterinarians

The U.S. Food and Drug Administration has made good on a decade-old promise to provide updated guidance on the regulatory complexities of compounding animal drugs from bulk substances.

No front page content has been created yet.